Interventions for visual field defects in patients with stroke

Alex Pollock, Christine Hazelton, Fiona J. Rowe, Sven Jonuscheit, Ashleigh Kernohan, Jayne Angilley, Clair A. Henderson, Peter Langhorne, Pauline Campbell

Research output: Contribution to journalLiterature review

Abstract

Background
Visual field defects are estimated to affect 20% to 57% of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living (commonly affectingmobility, reading and driving), quality of life, ability to participate in rehabilitation, and depression and anxiety following stroke. There are many interventions for visual field defects, which are proposed to work by restoring the visual field (restitution); compensating for the visual field defect by changing behaviour or activity (compensation); substituting for the visual field defect by using a device or extraneous modification (substitution); or ensuring appropriate diagnosis, referral and treatment prescription through standardised assessment or screening, or both.
Objectives
To determine the effects of interventions for people with visual field defects after stroke.
Search methods
We searched the Cochrane Stroke Group Trials Register, the Cochrane Eyes and Vision Group Trials Register, CENTRAL,MEDLINE, Embase, CINAHL, AMED, PsycINFO, and PDQT Databse, and clinical trials databases, including ClinicalTrials.gov and WHO Clinical Trials Registry, to May 2018. We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts.
Selection criteria
Randomised trials in adults after stroke, where the intervention was specifically targeted at improving the visual field defect or improving the ability of the participant to cope with the visual field loss. The primary outcome was functional ability in activities of daily living and secondary outcomes included functional ability in extended activities of daily living, reading ability, visual field measures, balance, falls, depression and anxiety, discharge destination or residence after stroke, quality of life and social isolation, visual scanning, adverse events, and death.
Original languageEnglish
Article numberCD008388
JournalCochrane Database of Systematic Reviews
DOIs
Publication statusPublished - 23 May 2019

Fingerprint

Visual Fields
Aptitude
Stroke
Activities of Daily Living
Reading
Anxiety
Quality of Life
Clinical Trials
Depression
Social Isolation
MEDLINE
Prescriptions
Registries
Referral and Consultation
Rehabilitation
Databases
Equipment and Supplies

Cite this

@article{af319f73074b4e098055cac11abe35e6,
title = "Interventions for visual field defects in patients with stroke",
abstract = "BackgroundVisual field defects are estimated to affect 20{\%} to 57{\%} of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living (commonly affectingmobility, reading and driving), quality of life, ability to participate in rehabilitation, and depression and anxiety following stroke. There are many interventions for visual field defects, which are proposed to work by restoring the visual field (restitution); compensating for the visual field defect by changing behaviour or activity (compensation); substituting for the visual field defect by using a device or extraneous modification (substitution); or ensuring appropriate diagnosis, referral and treatment prescription through standardised assessment or screening, or both.ObjectivesTo determine the effects of interventions for people with visual field defects after stroke.Search methodsWe searched the Cochrane Stroke Group Trials Register, the Cochrane Eyes and Vision Group Trials Register, CENTRAL,MEDLINE, Embase, CINAHL, AMED, PsycINFO, and PDQT Databse, and clinical trials databases, including ClinicalTrials.gov and WHO Clinical Trials Registry, to May 2018. We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts.Selection criteriaRandomised trials in adults after stroke, where the intervention was specifically targeted at improving the visual field defect or improving the ability of the participant to cope with the visual field loss. The primary outcome was functional ability in activities of daily living and secondary outcomes included functional ability in extended activities of daily living, reading ability, visual field measures, balance, falls, depression and anxiety, discharge destination or residence after stroke, quality of life and social isolation, visual scanning, adverse events, and death.",
author = "Alex Pollock and Christine Hazelton and Rowe, {Fiona J.} and Sven Jonuscheit and Ashleigh Kernohan and Jayne Angilley and Henderson, {Clair A.} and Peter Langhorne and Pauline Campbell",
note = "Acceptance as pub date (Cochrane reviews don't have acceptance stage) Uploaded publisher PDF, 12m embargo",
year = "2019",
month = "5",
day = "23",
doi = "10.1002/14651858.CD008388.pub3",
language = "English",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "Cochrane Collaboration",

}

Interventions for visual field defects in patients with stroke. / Pollock, Alex; Hazelton, Christine; Rowe, Fiona J.; Jonuscheit, Sven; Kernohan, Ashleigh; Angilley, Jayne; Henderson, Clair A.; Langhorne, Peter; Campbell, Pauline.

In: Cochrane Database of Systematic Reviews, 23.05.2019.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Interventions for visual field defects in patients with stroke

AU - Pollock, Alex

AU - Hazelton, Christine

AU - Rowe, Fiona J.

AU - Jonuscheit, Sven

AU - Kernohan, Ashleigh

AU - Angilley, Jayne

AU - Henderson, Clair A.

AU - Langhorne, Peter

AU - Campbell, Pauline

N1 - Acceptance as pub date (Cochrane reviews don't have acceptance stage) Uploaded publisher PDF, 12m embargo

PY - 2019/5/23

Y1 - 2019/5/23

N2 - BackgroundVisual field defects are estimated to affect 20% to 57% of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living (commonly affectingmobility, reading and driving), quality of life, ability to participate in rehabilitation, and depression and anxiety following stroke. There are many interventions for visual field defects, which are proposed to work by restoring the visual field (restitution); compensating for the visual field defect by changing behaviour or activity (compensation); substituting for the visual field defect by using a device or extraneous modification (substitution); or ensuring appropriate diagnosis, referral and treatment prescription through standardised assessment or screening, or both.ObjectivesTo determine the effects of interventions for people with visual field defects after stroke.Search methodsWe searched the Cochrane Stroke Group Trials Register, the Cochrane Eyes and Vision Group Trials Register, CENTRAL,MEDLINE, Embase, CINAHL, AMED, PsycINFO, and PDQT Databse, and clinical trials databases, including ClinicalTrials.gov and WHO Clinical Trials Registry, to May 2018. We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts.Selection criteriaRandomised trials in adults after stroke, where the intervention was specifically targeted at improving the visual field defect or improving the ability of the participant to cope with the visual field loss. The primary outcome was functional ability in activities of daily living and secondary outcomes included functional ability in extended activities of daily living, reading ability, visual field measures, balance, falls, depression and anxiety, discharge destination or residence after stroke, quality of life and social isolation, visual scanning, adverse events, and death.

AB - BackgroundVisual field defects are estimated to affect 20% to 57% of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living (commonly affectingmobility, reading and driving), quality of life, ability to participate in rehabilitation, and depression and anxiety following stroke. There are many interventions for visual field defects, which are proposed to work by restoring the visual field (restitution); compensating for the visual field defect by changing behaviour or activity (compensation); substituting for the visual field defect by using a device or extraneous modification (substitution); or ensuring appropriate diagnosis, referral and treatment prescription through standardised assessment or screening, or both.ObjectivesTo determine the effects of interventions for people with visual field defects after stroke.Search methodsWe searched the Cochrane Stroke Group Trials Register, the Cochrane Eyes and Vision Group Trials Register, CENTRAL,MEDLINE, Embase, CINAHL, AMED, PsycINFO, and PDQT Databse, and clinical trials databases, including ClinicalTrials.gov and WHO Clinical Trials Registry, to May 2018. We also searched reference lists and trials registers, handsearched journals and conference proceedings, and contacted experts.Selection criteriaRandomised trials in adults after stroke, where the intervention was specifically targeted at improving the visual field defect or improving the ability of the participant to cope with the visual field loss. The primary outcome was functional ability in activities of daily living and secondary outcomes included functional ability in extended activities of daily living, reading ability, visual field measures, balance, falls, depression and anxiety, discharge destination or residence after stroke, quality of life and social isolation, visual scanning, adverse events, and death.

U2 - 10.1002/14651858.CD008388.pub3

DO - 10.1002/14651858.CD008388.pub3

M3 - Literature review

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

M1 - CD008388

ER -